In raising an additional $4.28 million in venture capital funding, Tetra Discovery Partners LLC plans to support the ongoing clinical trials for a new drug to treat Alzheimer’s disease.
The Grand Rapids- and Kalamazoo-based Tetra Discovery Partners netted the funding as part of a $7.27 million Series A venture round that CEO Mark Gurney expects will successfully conclude within the next three months.